AllPennyStocks.com ARCT Defies mRNA Selloff And Extends Rally As Moderna, BioNTech Shares Pull Back
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

ARCT Defies mRNA Selloff And Extends Rally As Moderna, BioNTech Shares Pull Back

The rally around MRNA names began on Wednesday after Merck and Moderna reported positive late-stage results for their personalized mRNA cancer vaccine combined with Keytruda in high-risk melanoma patients.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
Chilean Gold Developer Gains 15% on Final Permit Clearance
Chile Copper Explorer Gains 19% on 795m Porphyry Hit
Most Popular
{{ index + 1 }}


Back to Top